Exploration Capital, LLC's Form 4 filing
Fresh Tracks Therapeutics, Inc. (FRTX) · filed May 23, 2024
- Accession no.
- 0001213900-24-046344
- Filed
- May 23, 2024
- Trade date
- May 21-23, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $20.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Common Stock | PPurchaseAcquired | +6,879 | $0.91 | +$6,259.89 | 1,307,468 | Direct | |
| May 22, 2024 | Common Stock | PPurchaseAcquired | +383 | $0.89 | +$340.87 | 1,307,851 | Direct | |
| May 23, 2024 | Common Stock | PPurchaseAcquired | +15,627 | $0.91 | +$14,220.57 | 1,323,478 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.